Clay B. Siegall
2014
In 2014, Clay B. Siegall earned a total compensation of $6.9M as President and CEO at Seattle Genetics, a 9% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $646,800 |
|---|---|
| Option Awards | $2,803,482 |
| Salary | $759,250 |
| Stock Awards | $2,645,400 |
| Other | $8,280 |
| Total | $6,863,212 |
Siegall received $2.8M in option awards, accounting for 41% of the total pay in 2014.
Siegall also received $646.8K in non-equity incentive plan, $759.3K in salary, $2.6M in stock awards and $8.3K in other compensation.
Rankings
In 2014, Clay B. Siegall's compensation ranked 979th out of 13,032 executives tracked by ExecPay. In other words, Siegall earned more than 92.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 979 out of 13,032 | 93rd |
Division Manufacturing | 353 out of 4,967 | 93rd |
Major group Chemicals And Allied Products | 116 out of 1,690 | 93rd |
Industry group Drugs | 91 out of 1,369 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 8 out of 241 | 97th |
Source: SEC filing on April 5, 2017.
Siegall's colleagues
We found five more compensation records of executives who worked with Clay B. Siegall at Seattle Genetics in 2014.
2014
Jonathan Drachman
Seattle Genetics
Chief Medical Officer
2014
Christopher Boerner
Seattle Genetics
Former EVP, Commercial
2014
Eric Dobmeier
Seattle Genetics
Chief Operating Officer
2014
Todd Simpson
Seattle Genetics
Chief Financial Officer
2014
Vaughn Himes
Seattle Genetics